Sep 22, 2017 12:01 pm UTC| Business
Trial now includes more than 730 patients under previously announced amended protocol Top-line results from TACTT3 expected in first quarter 2018 Zug, Switzerland, September 22, 2017 - Auris Medical Holding AG...
Catalyst Biosciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 22, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 22, 2017 -- Catalyst Biosciences, Inc. (Nasdaq:CBIO) today announced that Nassim Usman, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Ladenburg...
Global Content Analytics Market will Reach USD 8.1 Billion by 2022: Transparency Market Research
Sep 22, 2017 12:01 pm UTC| Business
Albany - NY, Sept. 22, 2017 -- The global content analytics market has been driven in the recent past by the steady development of big data analytics, which has enhanced the utility of content analytics to enterprises....
Casetify Announces Five Apple Watch Bands Capsule for New Apple Watch Series 3
Sep 22, 2017 12:01 pm UTC| Business
HONG KONG and LOS ANGELES, Sept. 22, 2017 -- Today, Casetify released an updated collection of five different style Apple Watch Bands that are compatible with all series including the new Apple Watch Series 3 in both...
Ekso Bionics Appoints Ted Wang to its Board of Directors
Sep 22, 2017 12:00 pm UTC| Business
RICHMOND, Calif., Sept. 22, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) (“Ekso” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of...
Sep 22, 2017 12:00 pm UTC| Business
RUTHERFORD, N.J., Sept. 22, 2017 -- Cancer Genetics, Inc. (Nasdaq:CGIX) (the Company and CGI), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced it will be...
Melinta Therapeutics to Participate in Two Upcoming Investor Conferences
Sep 22, 2017 12:00 pm UTC| Business
NEW HAVEN, Conn., Sept. 22, 2017 -- Melinta Therapeutics, a privately held commercial-stage company developing novel antibiotics to treat serious bacterial infections, announced that it will be presenting at the...